Reply to letter on central renal tumor ablation outcomes

Authors respond to a letter clarifying recurrence, bleeding risk, and procedural burden after central renal tumor ablation.

• The reply addresses methodology questions raised by the original letter.
• No new primary data are presented in this correspondence.

Full text of the reply is not available; content cannot be verified.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.